Abstract
Aims/Purpose: We report the case of a 70‐year‐old patient with chronic renal failure secondary to amyloidosis of undetermined etiology as well as multiple episodes of red eye with notion of self‐medication for 2 years consulting for an episode of red eye painful for 3 days.Methods: The ophthalmic examination revealed a best corrected visual acuity at counting fingers at 1 meter and light perception respectively in OD and in OS.Examination of the anterior segment showed a calm anterior segment in OD with normal ocular tonus and a grade 3 nuclear cataract and in OS a slight conjunctival hyperemia, ocular tonus at 30 mmHg, a 1+ flare and a dense morganian cataract.The ocular fundus was inaccessible in both eyes.The ocular ultrasound found a normal posterior segment in both eyes.Results: A phacolytic glaucoma diagnosis has been made and the patient was started on local steroid therapy and local and systemic antiglaucoma treatment and then benefited 3 days later from cataract surgery which took place without notable incident.The post‐operative period was marked by an improvement in visual acuity and a reduction in intraocular inflammation. Phacolytic glaucoma occurs mainly in the context of hypermature or even Morgagnian senile cataract. Over time, the cortical fibers of the lens degenerate into water‐soluble protein aggregates. These high molecular weight lens proteins escape through a grossly intact lens capsule into the anterior chamber, where they induce intense macrophage activity.Conclusions: Although curable, cataract remain the most significant cause of blindness in developing countries, mainly affecting the elderly.Delayed treatment leads to serious complications such as lens induced glaucoma, which can lead to irreversible vision loss. Cataract surgery is the most effective treatment for lowering IOP and restoring vision in these patients if undertaken early enough.References Macovei ML, Canache M, Neagoe BM. Phacolytic glaucoma ‐ case report. Rom J Ophthalmol. 2021 Apr‐Jun;65(2):191‐195. doi: 10.22336/rjo.2021.38. PMID: 34179587; PMCID: PMC8207859.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call